Dr. Sowsan H. Rasheid, MD

Dr. Rasheid practices at Lakeland Regional Health Systems, Inc. in Lakeland, Florida.

Dr. Rasheid's NPI, 1144493941, was assigned on April 12, 2008. Dr. Rasheid graduated from USF Health Morsani College of Medicine in 2002. Dr. Rasheid holds Florida license ME99897.

Dr. Rasheid's primary practice is Lakeland Regional Health Systems, Inc., at 3525 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 687-7251.

Dr. Rasheid's primary practice is Lakeland Regional Health Systems, Inc. in Lakeland, Florida. Dr. Rasheid is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Lakeland Regional Health. Dmand AI also links Dr. Rasheid to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rasheid practices. Vendor and product names are available with a free account.

Surgery is Dr. Rasheid's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Rasheid is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Rasheid's licenses on file in 2 states: Florida and New York.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Rasheid treats.

CMS data shows 146 Medicare services from Dr. Rasheid across 6 procedure codes in 2024, for 99 Medicare patients. Medicare paid $15,092 for them.

CMS counts 99 Medicare patients who saw Dr. Rasheid in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rasheid's median patient age at 60, with 57% women.

In 2024, Dr. Rasheid wrote 191 Medicare Part D claims for 81 patients. 98% of them were for generic drugs. CMS names the drug for 135 of them, across 5 drugs with 11 or more claims each, at $826 in total drug cost. In 2023, CMS named 105 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Rasheid for performance year 2024, reported as part of a group. Dr. Rasheid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of colonoscopy by Dr. Rasheid, more than 46% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Rasheid, published from 2021 to 2024. The most frequent topics are Anastomosis, Surgical, Rectal Neoplasms and Rectum. Dr. Rasheid has published most often in Am Surg. Dr. Rasheid's most frequent co-authors are Jorge Enrique Marcet, MD, Jaime E. Sanchez, MD and Michael Larone Campbell, MD.

Dmand AI links Dr. Rasheid to 1 clinical trial. Conditions studied include Rectal Neoplasms and Rectal Diseases.

CMS Open Payments shows 83 general payments to Dr. Rasheid from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Stryker Corporation paid the most, $28,275. It also lists 6 research payments totaling $46,962 from 2016 to 2017.

Dr. Rasheid graduated from USF Health Morsani College of Medicine in 2002.

Dr. Rasheid is in network with 19 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.